+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Histo compatibility typing by cyto toxic lymphocytes the hla a 2 28 hla b 5 w 35 serologically cross reactive groups reviewed by cyto toxic lymphocytes

Histo compatibility typing by cyto toxic lymphocytes the hla a 2 28 hla b 5 w 35 serologically cross reactive groups reviewed by cyto toxic lymphocytes

Tissue Antigens 17(5): 464-472

Using a standardized indirect cell-mediated lympholysis (CML) technique, cytotoxic lymphocytes (CTL) were raised between unrelated, fully HLA-A, B (and C) typed [human] individuals, differing only for 1 identified HLA-A, B antigenic determinant. Ten CTL involved HLA-A2+ stimulators and HLA-A2-, A28-, A9-responders. Five CTL involved HLA-Bw35+ stimulators and HLA-B5-, Bw35-, B15-, B17-, B18- and Bw21-responders. These CTL were tested for cell-mediated cytotoxicity against 2 different panels (20 and 9 cells, respectively) of HLA-A28+ and HLA-B5+ PHA[phytohemagglutinin]-lymphoblasts. The same panel cells were used as cold competitors for cytotoxicity against the specific 51Cr labeled targets. Most panel cells are neither lysed nor able to block; significant lysis is seen in the panels positive for serologically cross-reactive antigens, although lysis is generally lower than comparable lysis by anti-A28 or anti-B5 CTL. All target cells lysed in the A28 panel can inhibit specific lysis; 2 cells in the B5 panel are lysed but do not inhibit (Cytotoxicity-Positive-Inhibition-Negative = CYPIN). A group of panel cells cannot be lysed but can inhibit (Cytotoxicity-Negative-Inhibition-Positive = CYNIP). Cross-reactive groups identified by serology apparently may be identified by cellology using direct cytotoxicity and/or cold target inhibition. The cross-reactivity defined by CTL, as in serology, is inconstant and often incomplete. Whether the immunogenetic background of cross-reactivity as defined by antibody or CTL is identical is unknown but probable. The occurrence of CYNIP underlines that direct cytotoxicity and cold target inhibition are not directly comparable and indicates that different epitopes may be involved, although the discrepancy may be brought about by the experimental conditions used. The CYPIN phenomenon indicates the existence of immunodominant epitopes although non-T cell-mediated lysis cannot be excluded.

(PDF emailed within 1 workday: $29.90)

Accession: 005575644

Download citation: RISBibTeXText

Related references

The hla a 2 28 b 5w 35 serologically cross reactive groups reviewed by cyto toxic lymphocytes. Scandinavian Journal of Immunology 12(6): 537, 1980

Histo compatibility typing using in vitro produced cyto toxic lymphocytes. Tissue Antigens 10(3): 149, 1977

Cross priming for a secondary cyto toxic response to minor histo compatibility antigens with h 2 congenic cells which do not cross react in the cyto toxic assay. Journal of Experimental Medicine 143(5): 1283-1288, 1976

Differential recognition of the serologically defined hla a 2 antigen by allogeneic cyto toxic t cells 2. definition of 3 hla a 2 subtypes by cyto toxic t lymphocytes. Immunogenetics 17(6): 599-608, 1983

The role of cyclic amp in modulating cyto toxic thymus derived lymphocytes 1. in vivo generated cyto toxic lymphocytes but not in vitro generated cyto toxic lymphocytes are inhibited by cyclic amp active agents. Journal of Immunology 123(2): 692-701, 1979

Cyto toxic t lymphocytes detect tyrosine 155 tyrosine 156 as an immuno dominant determinant of h 2ld analysis of h 2 antigen structures by cyto toxic t lymphocytes cross reactivities. Immunobiology-4: 315, 1982

Human cyto toxic t lymphocytes against epstein barr virus infected cells epstein barr virus specificity and involvement of major histo compatibility complex determinants in the lysis exerted by anti epstein barr virus cyto toxic t lymphocytes toward hla compatible and allogeneic target cells. Cellular Immunology 83(2): 414-421, 1984

Recognition of human histo compatibility antigens by cyto toxic t lymphocytes. Journal of Supramolecular Structure & Cellular Biochemistry (SUPPL 5): 291, 1981

Quantitative studies on the precursors of cyto toxic lymphocytes part 9 specificity and cross reactivity of cyto toxic clones. Journal of Immunology 120(2): 425-428, 1978

Analysis of allo reactive and cyto toxic canine lymphocytes and their precursors with murine mono clonal antibodies expression of ia antigens on cyto toxic effector cells. Transplantation (Baltimore) 35(5): 469-473, 1983

Histocompatibility typing by cytotoxic lymphocytes. The HLA-A2-28, B5-w35 serologically cross-reactive groups reviewed by cytotoxic lymphocytes. Tissue Antigens 17(5): 464-472, 1981

Mechanisms of in vivo generation of cyto toxic activity against allo graft 1. local differentiation of mature cyto toxic t lymphocytes in rejection of allogeneic lymphocytes. Cellular Immunology 54(2): 321-329, 1980

The origin of cyto toxic t lymphocyte precursors major histo compatibility complex restricted and allo reactive cyto toxic t lymphocyte precursors in the spleen during regeneration after a sublethal dose of cyclo phosphamide. Journal of Immunology 130(3): 1077-1083, 1983

Cyto toxic reactions of nzb spleen cells with lymphocytes of major histo compatibility identical strains. Federation Proceedings 37(6): 1373, 1978

Hla d histo compatibility antigen related ia antigens are targets for cyto toxic thymus derived lymphocytes. Clinical Research 26(3): 514A, 1978